Pharmacology News and Research

Latest Pharmacology News and Research

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Triciribine drug may reverse progression of pulmonary fibrosis and pulmonary hypertension

Triciribine drug may reverse progression of pulmonary fibrosis and pulmonary hypertension

Adding high salt to high-fat diet prevents weight gain in mice

Adding high salt to high-fat diet prevents weight gain in mice

Researchers identify two critical mutations that allow MERS virus to transmit from bats to humans

Researchers identify two critical mutations that allow MERS virus to transmit from bats to humans

Novel combination of non-toxic dietary and hyperbaric oxygen therapies doubles survival time in cancer model

Novel combination of non-toxic dietary and hyperbaric oxygen therapies doubles survival time in cancer model

Study on how maternal proteins help regulate initial cell divisions during early development

Study on how maternal proteins help regulate initial cell divisions during early development

UC Davis funds BRAIN-STIM program to uncover potential treatments for neurodegenerative disorders

UC Davis funds BRAIN-STIM program to uncover potential treatments for neurodegenerative disorders

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

Once-weekly Trulicity 0.75 mg shows promising results in Japanese patients with type 2 diabetes

Profil Institute for Clinical Research forms strategic partnership with Gubra

Profil Institute for Clinical Research forms strategic partnership with Gubra

Feinberg physiology professor named recipient of 2015 AES Seed Grant

Feinberg physiology professor named recipient of 2015 AES Seed Grant

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

HarkerBIO, AMRI sign collaborative agreement to market structure-based drug discovery services

HarkerBIO, AMRI sign collaborative agreement to market structure-based drug discovery services

AstraZeneca presents preliminary data from AZD6094-AZD9291 combination trial for treatment of NSCLC

AstraZeneca presents preliminary data from AZD6094-AZD9291 combination trial for treatment of NSCLC

Two grants to bolster research on why ovarian cancer is resistant to chemotherapy

Two grants to bolster research on why ovarian cancer is resistant to chemotherapy

'Conflict of Interest and Scientific Discovery' symposium to be held at Penn’s Perelman School of Medicine

'Conflict of Interest and Scientific Discovery' symposium to be held at Penn’s Perelman School of Medicine

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

Practical guidance to ensure safe use of flavourings in e-cigarettes

Practical guidance to ensure safe use of flavourings in e-cigarettes

Study shows differences in rates of paracetamol-linked acute liver failure among European countries

Study shows differences in rates of paracetamol-linked acute liver failure among European countries

UB researchers identify mechanisms behind some autistic behaviors, suggest potential targets

UB researchers identify mechanisms behind some autistic behaviors, suggest potential targets

Pitt scientists identify two new classes of RNAs closely associated with cancer biomarker

Pitt scientists identify two new classes of RNAs closely associated with cancer biomarker

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.